gMendel® announces CE marking for its Phivea® v1.0.0 platform - #BHHMembersInitiatives
Become a member
About us
Overview The Team Ambassadors Location & Contact Get your office at the Hub
Members
Members Become a member
Events
Next events Past events ISE 2026 4YFN 2026 Health Revolution Congress Organize your event at BHH
Reports
Digital Health Reports
e-health validations
News
Recinte Modernista de Sant Pau
Carrer de Sant Antoni Maria Claret 167
08025 Barcelona, Spain
Home News gMendel® announces CE marking for its Phivea® v1.0.0 platform - #BHHMembersInitiatives
Back

gMendel® announces CE marking for its Phivea® v1.0.0 platform - #BHHMembersInitiatives

MAY 6, 2022 BHH News
BHH member gMendel®, a Danish medical technology startup aiming to transform the diagnosis of genetic disorders for better disease management, announced today it has achieved CE marking for its Phivea® v1.0.0 platform, a novel screening technology for the detection of Klinefelter Syndrome. Following the successful validation and a comprehensive performance evaluation, documenting the clinical applicability of its technology, gMendel® is now entitled to sell the Phivea® v1.0.0 platform in the EU, starting with a registration in Denmark. The Phivea® v1.0.0 platform will be marketed as an In Vitro Diagnostic (IVD) medical device product under the Directive 98/79/EC for In Vitro Diagnostic medical devices. “The CE marking of the Phivea® v1.0.0 platform is a major milestone for gMendel®”, said Zoran Velkoski, co-founder of gMendel®. “In parallel with our strong patent portfolio strategy, our recently-obtained ISO 13485 certification and the CE marking pave the way for the commercial launch of more advanced products in the highly competitive IVD market, as defined in our product roadmap”, explained Zoran Velkoski.  About the Phivea® v1.0.0 platform Phivea® v1.0.0 is an in vitro screening software tool for the diagnosis of Klinefelter syndrome based on DNA sequencing process. It offers screening tests capabilities, based on the data coming from third-party genome sequencers. Phivea® employs advanced Artificial Intelligence and customized Deep Learning architectures at all levels of the learning process, from feature extraction to assessment and follow-up care. Following a multi model fusion strategy, the Platform combines outcomes of individual models into a single, accurate medical interpretation. More about Phivea® v1.0.0 here. About CE marking for medical devices Many products require CE marking before they can be sold in the EU. CE marking indicates that a product has been assessed by the manufacturer and deemed to meet EU safety, health and environmental protection requirements. The CE marking affixed to a medical device demonstrates compliance with the EU legislation in force and therefore can be made available for distribution or use, e.g. to a distributor, healthcare professional or patient. More about CE marking in medical devices here.  
You may also like
 See all
February 13, 2026 BHH News
VASS and Cesce Showcase the Digital Rebirth of Cesce’s Core Platform at Insurance Week 2026
As part of Insurance Week 2026, organized by INESE, VASS will present, together with Cesce, a real-life case of digital transformation that demonstrates how true success lies not only in technology but in its ability to adapt to the needs of its users.
Read more
February 13, 2026 BHH News
CRA & connected product readiness: When are connected devices truly ready for 2027?
A strategic perspective on cyber resilience. Change is constant. In technology, it’s systemic. The Cyber Resilience Act (CRA) is not just another regulation – it’s a structural shift that redefines how connected products must be designed, built and maintained. The deadline is 2027. But readiness starts now.
Read more
February 13, 2026 BHH News
Omnichannel Specialist Certification for the Pharma Industry
Registrations are now open for the Omnichannel Specialist Certification for the Pharma Industry, a professional training program developed by Unlimited Thinking in collaboration with Blanquerna – Universitat Ramon Llull.
Read more
February 13, 2026 BHH News
IESE MBA Summer Projects: strategic support for your organization
IESE Business School is inviting organizations from the health, life sciences, and digital health ecosystem to collaborate through its MBA Summer Projects program.
Read more
February 13, 2026 BHH News
Scilife Training | Preparing for EUDAMED: what medical device companies need to do now
With the phased rollout of EUDAMED approaching, many MedTech companies still lack clarity on what it is, who must register, and how to prepare.
Read more
February 13, 2026 BHH News
Investor Demo Day with 2EyesVision at CSIC
Madrid Health Hub is pleased to share an upcoming investor-focused event hosted by 2EyesVision at the CSIC Campus in Madrid.
Read more
February 13, 2026 BHH News
From Local Success to UK Adoption
Barcelona Health Hub will host an in-person session led by Marco Aldovardi exploring what determines successful adoption of digital health, AI, and medtech solutions in the UK.
Read more
February 13, 2026 BHH News
Kraz Webinar: SKU-Level Demand Forecasting in the Pharma Sector
Kraz, an AI solutions and advanced analytics consultancy, is hosting a technical webinar focused on demand forecasting at SKU level in the pharmaceutical sector.
Read more
February 06, 2026 BHH News
NEWLINK opens a new office in Barcelona
Newlink and Both, the Culture Division of Newlink, consolidate their integration process and open a new office in Barcelona. Eduardo Menal appointed Managing Director of Newlink in Barcelona. Cristina Salvador, President of Both, the Culture Division of Newlink, expands her scope of responsibility by taking on the international development of the Culture division.
Read more
February 05, 2026 BHH News
TuoTempo Webinar | Omnichannel Healthcare: Transforming the Patient Experience with AI
TuoTempo, a provider of digital patient journey and access management solutions for healthcare organizations, will host a live webinar focused on how omnichannel strategies are reshaping patient experience and operational efficiency in hospitals and clinics.
Read more